Search

Your search keyword '"BrÅthen, Geir"' showing total 300 results

Search Constraints

Start Over You searched for: Author "BrÅthen, Geir" Remove constraint Author: "BrÅthen, Geir"
300 results on '"BrÅthen, Geir"'

Search Results

1. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

2. Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease

3. New insights into the genetic etiology of Alzheimer’s disease and related dementias

4. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

5. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

6. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

9. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

11. Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis

13. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

15. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

18. Author Correction: A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

19. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

20. A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

24. Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample

26. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

27. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci

28. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

31. Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients

32. Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: protocol for the ExPlas study

33. Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

34. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations

35. Clinical trials in pediatric ALS: a TRICALS feasibility study

38. Karakteristika ved pasienter med Motornevronsykdom i Nord-Trøndelag fra 1984 til 2018

46. Hjerneovervåking i sykehusene må styrkes

48. Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study (Scientific Reports, (2019), 9, 1, (7013), 10.1038/s41598-019-43458-2)

Catalog

Books, media, physical & digital resources